Garber S L, Cohen E P, Chang I
Leuk Res. 1984;8(2):255-66. doi: 10.1016/0145-2126(84)90149-8.
Hybrids of ASL-1 murine leukemia cells and LM(TK-) cells, a cultured line of mouse fibroblast origin, stimulate partial immunity toward ASL-1 cells in (A/J X C3H/HeJ)F1 mice (F1 mice). Such mice ordinarily exhibit no resistance to the malignant proliferation of ASL-1 cells. Unprotected animals invariably die within 14-18 days after receiving as few as 200 ASL-1 cells. The hybrid cells, the mice used in the experimental studies and the leukemia cells used for challenge all share the same histocompatibility antigens. ASL-1 cells are H-2a; LM(TK-) cells are H-2k, both ASL-1 X LM(TK-) hybrid cells and A/J X C3H/HeJ)F1 mice are H-2a/k. The long-term persistence of the immunoprotective properties of the hybrid cells toward murine leukemia was investigated by using cells that had been in continuous culture for approx. 36 months. (A/J X C3H/HeJ)F1 mice injected previously with hybrid cells in continuous culture and then challenged with up to 10(7) ASL-1 cells survived longer (p less than 0.001) than mice who had not received hybrid cells previously. Some mice challenged with lesser number of ASL-1 cells survived indefinitely (greater than 200 days). The median survival time of F1 mice injected simultaneously with 10(7) hybrid cells and 200 or 2000 ASL-1 cells was significantly (p less than 0.001) prolonged as well, although the differences between experimental and control groups are less pronounced than if the hybrid cells were injected before challenge with ASL-1 cells. The hybrid cells like those freshly prepared continue to be rejected by histocompatible precipients. In no instance has there been evidence of a progressively growing tumor of hybrid cells in immunocompetent F1 mice. Hybrid cells like those investigated previously do form rapidly growing metastasizing tumors in immunodeficient nu/nu (BALB/c) or X-irradiated (550 R) F1 mice. The cells possess approx. 70 chromosomes (reduced from 85) including chromosomes identified as having originated in each parental source. Like (A/J X C3H/HeJ)F1 animals, they continue to express both H-2a and H-2k antigenic determinants.
ASL-1小鼠白血病细胞与LM(TK-)细胞(一种源自小鼠成纤维细胞的培养细胞系)的杂交细胞,可刺激(A/J×C3H/HeJ)F1小鼠(F1小鼠)对ASL-1细胞产生部分免疫。这类小鼠通常对ASL-1细胞的恶性增殖没有抵抗力。未受保护的动物在接种低至200个ASL-1细胞后14 - 18天内必然死亡。杂交细胞、实验研究中使用的小鼠以及用于攻击的白血病细胞都具有相同的组织相容性抗原。ASL-1细胞是H-2a;LM(TK-)细胞是H-2k,ASL-1×LM(TK-)杂交细胞和A/J×C3H/HeJ)F1小鼠都是H-2a/k。通过使用连续培养约36个月的细胞,研究了杂交细胞对小鼠白血病免疫保护特性的长期持续性。先前接种了连续培养杂交细胞然后接受多达10(7)个ASL-1细胞攻击的(A/J×C3H/HeJ)F1小鼠比未预先接受杂交细胞的小鼠存活时间更长(p<0.001)。一些接受较少数量ASL-1细胞攻击的小鼠存活了很长时间(超过200天)。同时接种10(7)个杂交细胞和200或2000个ASL-1细胞的F1小鼠的中位存活时间也显著延长(p<0.001),尽管实验组和对照组之间的差异不如在ASL-1细胞攻击前接种杂交细胞那么明显。与新制备的杂交细胞一样,这些杂交细胞继续被组织相容性受体排斥。在具有免疫能力的F1小鼠中,没有证据表明杂交细胞会逐渐形成生长中的肿瘤。与之前研究的杂交细胞一样,这些杂交细胞在免疫缺陷的裸鼠/裸鼠(BALB/c)或经X射线照射(550 R)的F1小鼠中确实会形成快速生长的转移性肿瘤。这些细胞拥有约70条染色体(从85条减少),包括已确定源自每个亲本来源的染色体。与(A/J×C3H/HeJ)F1动物一样,它们继续表达H-2a和H-2k抗原决定簇。